Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesCognitive Effects of Second-Generation Antipsychotics: Current Insights into Neurochemical Mechanisms
CNS Drugs, 06/29/09
Fumagalli F et al. - The authors discuss recent preclinical research efforts, including investigation of synaptic mechanisms as well as intracellular signalling pathways and mechanisms involved in neuroplasticity and cell resilience, that may represent new mechanisms participating in the pathogenesis of schizophrenia, particularly at the level of the prefrontal cortex and hippocampus, and that might lead to the development of drugs that can counteract, at least partially, the cognitive impairments typical of schizophrenia.
Related Articles
Auditory gating deficit to human voices in schizophrenia: A MEG study
Schizophrenia Research, 10/01/09
Relevance Score: 93%
Age at onset and cognition in schizophrenia: meta-analysis
British Journal of Psychiatry, 10/06/09
Relevance Score: 92%
Beyond symptom dimensions: Schizophrenia risk factors for patient groups derived by latent class analysis
Schizophrenia Research, 10/30/09
Relevance Score: 91%
Functional Magnetic Resonance Imaging of Inner Speech in Schizophrenia
Biological Psychiatry, 10/26/09
Relevance Score: 91%
Sensory Processing in Schizophrenia: Neither Simple nor Intact
Schizophrenia Bulletin, 10/19/09
Relevance Score: 91%
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/14/09
Atomoxetine Attenuates Dextroamphetamine Effects in Humans
American Journal of Drug & Alcohol Abuse, 12/14/09
History of early abuse as a predictor of treatment response in patients with fibromyalgia: A post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release
World Journal of Biological Psychiatry, 12/14/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/14/09
Atomoxetine Attenuates Dextroamphetamine Effects in Humans
American Journal of Drug & Alcohol Abuse, 12/14/09
History of early abuse as a predictor of treatment response in patients with fibromyalgia: A post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release
World Journal of Biological Psychiatry, 12/14/09
Today in Neuropsych Sciences...keeping you current
Receive free subspecialty "5-minute updates" via email
Single- and Multiple-Domain Amnestic Mild Cognitive Impairment: Two Sides of the Same Coin?
Dementia and Geriatric Cognitive Disorders, 12/14/09
Incidence of Parkinson's Disease in Bulgaria
Neuroepidemiology , 12/14/09
Evaluation of the Usability of a Brief Computerized Cognitive Screening Test in Older People for Epidemiological Studies
Neuroepidemiology , 12/14/09
Today in Schizophrenia/Psychosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia
Current Medical Research and Opinion, 12/14/09
Clozapine Use in HIV-Infected Schizophrenia Patients: A Case-Based Discussion and Review
Psychosomatics, 12/14/09
Registered criminality and sanctioning of schizophrenia patients
Nordic Journal of Psychiatry, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor